Literature DB >> 32933609

Onset of Coronary Heart Disease is Associated with HCMV Infection and Increased CD14 +CD16 + Monocytes in a Population of Weifang, China.

Hong Zheng Li1, Qin Wang2, Yi Yuan Zhang3, Jin Dong Wang1, Hong Juan Wu4, Mo Gen Zhang3, Ji Chen Li1, Zhi Jun Liu1.   

Abstract

OBJECTIVE: To investigate the relationship between human cytomegalovirus (HCMV) infection and peripheral blood CD14 +CD16 + monocytes in the pathogenesis of coronary heart disease (CHD), and to elucidate the mechanism of pathogenesis in CHD by analyzing the correlation between infection, inflammation, and CHD, to provide a basis for the prevention, evaluation, and treatment of the disease.
METHODS: In total, 192 patients with CHD were divided into three groups: latent CHD, angina pectoris, and myocardial infarction. HCMV-IgM and -IgG antibodies were assessed using ELISA; CD14 +CD16 + monocytes were counted using a five-type automated hematology analyzer; mononuclear cells were assessed using fluorescence-activated cell sorting; and an automatic biochemical analyzer was used to measure the levels of triglyceride, cholesterol, high- and low-density lipoprotein cholesterols, lipoprotein, hs-CRp and Hcy.
RESULTS: The positive rates of HCMV-IgM and -IgG were significantly higher in the CHD groups than in the control group. HCMV infection affects lipid metabolism to promote immune and inflammatory responses.
CONCLUSION: HCMV infection has a specific correlation with the occurrence and development of CHD. The expression of CD14 +CD16 + mononuclear cells in the CHD group was increased accordingly and correlated with acute HCMV infection. Thus, HCMV antibody as well as peripheral blood CD14 +CD16 + mononuclear cells can be used to monitor the occurrence and development of CHD.
Copyright © 2020 The Editorial Board of Biomedical and Environmental Sciences. Published by China CDC. All rights reserved.

Entities:  

Keywords:  Antibody; CD14+CD16+ monocytes; Coronary heart disease; Human cytomegalovirus; Weifang

Mesh:

Year:  2020        PMID: 32933609     DOI: 10.3967/bes2020.076

Source DB:  PubMed          Journal:  Biomed Environ Sci        ISSN: 0895-3988            Impact factor:   3.118


  2 in total

1.  Decoding the Mechanism of Shixiao Powder in Treating Coronary Heart Disease Based on Network Pharmacology and Molecular Docking.

Authors:  Zuo-Min Jiang; Tong Wu; Yi-Tao Xue; Yan Li; Gui-Hua Li; Kai Huang; Hua-Jing Yuan; Meng-Qi Du
Journal:  Evid Based Complement Alternat Med       Date:  2022-07-06       Impact factor: 2.650

Review 2.  Diagnostic and Prognostic Value of Monocyte Distribution Width in Sepsis.

Authors:  Juehui Wu; Laisheng Li; Jinmei Luo
Journal:  J Inflamm Res       Date:  2022-07-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.